Federal award (DEFINITIVE CONTRACT, fiscal year 2024)
Recipient: MICROBIOTIX, INC.
Awarding agency: Department of Defense / Defense Contract Management Agency
Funding agency: Department of Defense / Defense Threat Reduction Agency
Period of performance: 2017-12-15 to 2018-12-14
Current total value of award: $2594319.91
Description: DEVELOP NOVEL AND INNOVATIVE SMALL MOLECULE THERAPEUTICS TO TREAT (POST-EXPOSURE THERAPEUTIC) INFECTIONS BY BOTH FILOVIRUS FAMILY MEMBERS (EBOLA VIRUSES AND MARBURG VIRUSES).